Mr. Market’s Giving Us a Gift With Shares of This Stock Selling Off

Key Concepts

• Axon's Q3 Financial Performance
• Revenue Growth (31%)
• Annual Recurring Revenue (ARR) Growth (41%)
• Software and Services Revenue Growth (41%)
• Full-Year Guidance Increase
• Profitability Concerns (Bottom Line)
• Research and Development (R&D) Investment
• Market Reaction to Earnings
• Long-Term Investment Thesis

Axon's Third Quarter Results and Market Reaction

Axon's stock experienced a decline following its third-quarter earnings report. Despite this negative market reaction, the quarter was characterized by strong operational performance. Revenue saw a significant increase of 31%, marking the seventh consecutive quarter of revenue growth exceeding 30% and the fifteenth consecutive quarter of growth surpassing 25%.

Growth in Recurring Revenue Streams

Key drivers of this revenue expansion include substantial growth in both Annual Recurring Revenue (ARR) and software and services revenue, both of which grew by an impressive 41%. This indicates a strengthening recurring revenue base for the company.

Leadership's Optimism and Full-Year Guidance

In light of these positive results, Axon's leadership decided to increase its full-year guidance. This suggests confidence in the company's continued performance trajectory.

The Disconnect: Profitability vs. Growth

The primary reason cited for the stock's downturn is the market's dissatisfaction with the company's bottom line, or profitability. However, the transcript emphasizes that this focus on profitability has always been a secondary consideration within Axon's long-term investment thesis.

Strategic Investment in Research and Development (R&D)

Axon's strategy involves significant investment in its business to capitalize on expanding market opportunities. A prime example of this is the company's substantial allocation to Research and Development (R&D) expenses. R&D expenditure has risen from 17.5% of total revenue in 2020 to 24.5% currently. This increase is framed as a deliberate strategic choice ("a feature, not a bug") rather than an anomaly.

A Predicted "Hiccup" and Opportunity for Long-Term Investors

The speaker had previously anticipated this potential short-term market reaction to profitability concerns in an article published the previous week, and this prediction has now materialized. While acknowledging that the stock price could decline further in the immediate future, the speaker believes that the current market sentiment is creating a valuable "window of opportunity" for long-term investors in Axon.

Synthesis and Conclusion

Axon delivered a strong third quarter with robust revenue growth (31%) and significant expansion in its recurring revenue segments (ARR and software/services up 41%). Leadership responded by raising full-year guidance. However, the market reacted negatively to the company's profitability, a factor that has been a known element of Axon's growth-oriented strategy. The substantial increase in R&D spending (from 17.5% in 2020 to 24.5% currently) is a deliberate investment to capture market opportunities. Despite the short-term stock price dip, the speaker views this as a potential buying opportunity for long-term shareholders, aligning with a previously identified potential market "hiccup."